Treatment Landscape of Targeted Therapies in Oncology
Challenges and Opportunities
- 1st Edition - August 1, 2023
- Editors: Pawan Kumar Maurya, Vikas Saini
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 6 0 3 4 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 6 0 3 5 - 6
Treatment Landscape of Targeted Therapies in Oncology: Challenges and Opportunities provides up-to-date knowledge on antitumor-targeted therapies and immunotherapy. The book's… Read more
Treatment Landscape of Targeted Therapies in Oncology: Challenges and Opportunities provides up-to-date knowledge on antitumor-targeted therapies and immunotherapy. The book's chapters are written by researchers dynamically working/focusing on cancer treatment. The content is designed to help those who are new to the field (beginners) and various specialized scientists and researchers involved in cancer research. For decades, the hallmark of cancer treatment has been conventional chemotherapy. But with the rapid increase in our understanding of the immune system, more and more small molecules, peptides, recombinant antibodies, vaccines and cellular therapeutic modalities are being applied to manipulate the immune response for cancer treatment.
- Covers basic concepts and updated knowledge of the latest anticancer drugs
- Brings comprehensive understanding of the treatment of cancer in context of immunotherapy and targeted therapy
- Introduces the latest drugs and advancements in the treatment of cancer
- Includes detailed diagrams to give insight to the mechanisms of action
Undergraduate, postgraduate and doctoral students of biomedical sciences, biotechnology, microbiology, biochemistry, immunology, pharmacy, pharmaceutical sciences, bioinformatics, translational research, medical sciences stream. Professional working in oncology with a broad range of cancer treatments looking for updated knowledge of newer targeted and immune-based therapies
1. Preface2. Biology of Cancer: Current Insights and Perspectives3. Evolution of Targeted Therapies in Cancer: Opportunities and Challenges4. Clinical Implementations of Novel Targeted Therapeutics in Advanced Breast Cancer5. Targeted Therapies in Advanced Lung Cancer: Current Landscape And Future Projects6. Targeted Therapies: Emerging Biomarkers in Advanced Melanoma7. Targeted Therapies in Hematological Malignancies8. Glioblastoma Targeted Therapies: Updated Approaches from Recent Biological Insights9. Current Trends and Future Prospects of Molecular Targeted Therapy in Head And Neck Squamous Carcinoma10. Progress and Current Status of Targeted Therapy and Drug Resistance in Gastric and Pancreatic Cancer11. Colorectal Cancer Heterogenity and Targeted Therapy: Clinical Implications, Challenges and Solutions for Treatment Resistance12. Endometrial Cancer: Molecular Markers and Management of Advanced Stage Disease13. Bibliography14. Glossary
- Edition: 1
- Published: August 1, 2023
- Language: English
PM
Pawan Kumar Maurya
Prof. Pawan Kumar Maurya is Dean, School of Life Long Learning & Head of Department of Biochemistry, Central University of Haryana, India. He has done a PhD from the University of Allahabad (A Central University), India & post-doctoral training from Universidade Federal de Sao Paulo-UNIFESP, Brazil; Taipei Medical University (TMU) and National Taiwan University (NTU), Taiwan. He has more than 14 years of teaching and research experience. He is working on biochemical diagnostics, nanomedicine, and clinical biochemistry. He has published over 75 research articles in reputed journals. He has also edited of six books published from Elsevier, USA and Springer-Nature, Singapore. He is recipient of prestigious fellowships: Science without Borders (Government of Brazil) and National Science Council, Taiwan.
Affiliations and expertise
Central University of Haryana, Mahendergarh (Haryana), IndiaVS
Vikas Saini
Dr. Vikas Saini is working as an Assistant professor and Coordinator of Biomedical Sciences program under Department of Vocational Studies and Skill Development, Central University of Haryana, India. His area of interest is Cancer biology and drug discovery. He earned his Ph.D. in biomedical Sciences from Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi with an emphasis on identifying novel anticancer molecules. He has research experiences in the area of cheminformatics, drug synthesis, and cancer biology. He has more than 4 years of teaching experience and published several research articles and book chapters in reputed journals. He is currently working on testing novel compounds against cancer.
Affiliations and expertise
School of Lifelong Learning, Central University of Haryana, Mahendergarh (Haryana), IndiaRead Treatment Landscape of Targeted Therapies in Oncology on ScienceDirect